英国《自然》杂志最近报道,1982年9月美国Eli Lilly公司采用遗传工程技术生产的一种人胰岛素(商品名Humulin)被批准在英国出售。继后,10月29日美国食品和药物管理局(FDA)也批准该产品在美国投放市场。Humulin最初由美国加州Genentech公司研制成功,交Lilly公司正式投产。虽然它的售价大约比猪和牛获制的胰岛素贵两倍,但它具有一个很大的优点:此新 A recent report by the British journal Nature showed that human insulin (Humulin), produced by the Eli Lilly Company of the United States in 19882 and genetically engineered, has been approved for sale in the United Kingdom. Then, on October 29, the U.S. Food and Drug Administration (FDA) also approved the product to be launched in the United States. Humulin was originally developed by the Genentech company in California, USA, and Lilly was officially put into production. Although it costs about twice as expensive as pigs and cattle, it has one big advantage: this new